» Articles » PMID: 35924026

Patient Activation Among Prevalent Hemodialysis Patients: An Observational Cross-Sectional Study

Overview
Journal J Patient Exp
Specialty Health Services
Date 2022 Aug 4
PMID 35924026
Authors
Affiliations
Soon will be listed here.
Abstract

Patient activation is the product of knowledge, skills, and confidence that enables a person to manage their own healthcare. It is associated with healthy behaviors and improved patient outcomes. We surveyed prevalent hemodialysis (HD) patients at 10 centers using the Patient Activation Measure 13-item instrument (PAM-13). Activation was reported as scores (0-100) and corresponding levels (1-4). Of 1149 eligible patients, surveys were completed by 925 patients (92% response rate). Mean age was 62 ± 14 years, 40% were female, median vintage was 41 (IQR 19-77) months, and 66% had diabetes. Mean PAM score was 56 ± 13, with 14%, 50%, 25%, and 10% in levels 1 to 4, respectively. In adjusted analysis, older age and having diabetes were associated with lower activation, whereas higher educational levels and female gender were associated with higher scores. Significant variation in activation was observed among participants from different centers even after adjustment for other variables. In conclusion, low activation is common among prevalent HD patients.

Citing Articles

Factors associated with patient activation among patients with diabetes on hemodialysis: a multicenter cross-sectional study from a developing country.

Zeidalkilani J, Milhem Y, Shorafa R, Taha S, Koni A, Al-Jabi S BMC Nephrol. 2024; 25(1):232.

PMID: 39033115 PMC: 11265049. DOI: 10.1186/s12882-024-03674-z.


Patient activation in advanced chronic kidney disease: a cross-sectional study.

Lunardi L, Le Leu R, Matricciani L, Xu Q, Britton A, Jesudason S J Nephrol. 2024; 37(2):343-352.

PMID: 38345687 PMC: 11043190. DOI: 10.1007/s40620-023-01847-x.

References
1.
Hibbard J, Greene J . What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013; 32(2):207-14. DOI: 10.1377/hlthaff.2012.1061. View

2.
Lin M, Weng W, Apriliyasari R, Van Truong P, Tsai P . Effects of Patient Activation Intervention on Chronic Diseases: A Meta-Analysis. J Nurs Res. 2020; 28(5):e116. DOI: 10.1097/jnr.0000000000000387. View

3.
Morton R, Sellars M . From Patient-Centered to Person-Centered Care for Kidney Diseases. Clin J Am Soc Nephrol. 2019; 14(4):623-625. PMC: 6450337. DOI: 10.2215/CJN.10380818. View

4.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

5.
Parchman M, Zeber J, Palmer R . Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010; 8(5):410-7. PMC: 2939416. DOI: 10.1370/afm.1161. View